A detailed history of Monaco Asset Management Sam transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 25,000 shares of OLMA stock, worth $126,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$126,000
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$5.61 - $12.72 $140,250 - $318,000
25,000 New
25,000 $145,000
Q2 2023

Aug 08, 2023

SELL
$3.22 - $9.65 $676,509 - $2.03 Million
-210,096 Reduced 94.68%
11,809 $106,000
Q1 2023

May 11, 2023

SELL
$2.55 - $4.97 $330,510 - $644,171
-129,612 Reduced 36.87%
221,905 $770,000
Q4 2022

Jan 31, 2023

BUY
$2.27 - $3.76 $377,378 - $625,084
166,246 Added 89.73%
351,517 $861,000
Q3 2022

Oct 31, 2022

BUY
$2.72 - $5.88 $150,337 - $324,993
55,271 Added 42.52%
185,271 $511,000
Q2 2022

Aug 01, 2022

BUY
$2.04 - $4.61 $265,200 - $599,300
130,000 New
130,000 $529,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $204M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.